COVID-like symptom prevalence studied up to 12 months after positive or negative SARS-CoV-2 tests in US adults

This observational study examined the prevalence of COVID-like symptoms among adults in the United States for up to 12 months following either a positive or negative SARS-CoV-2 test. The exposure was a positive SARS-CoV-2 test, with a comparator group of individuals who tested negative. The primary outcome was the prevalence of symptoms within 12 months after the acute illness phase.

No main results were reported for the study. The prevalence of symptoms, effect sizes, absolute numbers, p-values, confidence intervals, and direction of association were all listed as 'not reported' in the available data. Secondary outcomes were not specified.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported. The study's limitations were not detailed in the provided information, and funding sources or potential conflicts of interest were also not reported.

Given the complete absence of reported numerical results, this study currently offers no quantifiable evidence regarding the long-term prevalence of post-acute symptoms. Its practice relevance cannot be assessed without the core findings. Clinicians should await the publication of complete data before drawing any conclusions.